Compare ADMA Biologics Inc (ADMA) vs Braze Inc (BRZE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ADMA Biologics Inc vs Braze Inc — how do they compare? ADMA Biologics Inc trades at $9.81 (market cap $2.22B), while Braze Inc trades at $27.77 (market cap $3.18B). The key difference: Braze Inc is the larger of the two by market cap, and Braze Inc is trading nearer its 52-week high, ADMA Biologics Inc nearer its low. Which is the better fit depends on your goals.
| ADMA | BRZE | |
|---|---|---|
Market Cap | $2.22B | $3.18B |
Sector | Health | Technology |
52-Week High | $20.38 | $36.19 |
52-Week Low | $7.60 | $15.79 |
Enterprise Value | $2.29B | $2.87B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About Braze Inc
Braze Inc is a customer engagement platform that powers customer-centric interactions between consumers and brands. The company provides solutions for Retail & E-commerce, Media & Entertainment, Financial Services, and Travel & Hospitality related industries.
Read more on BRZE →
